Evidence map›Paper›PMID 40921062›Full record

Observational studyJMIR aging2025

Changes in Sarcopenia Status and Subsequent Cardiovascular Outcomes: Prospective Cohort Study.

Yuanyue Zhu, Kan Wang, Zuolin Lu, Feika Li, Yu Xu, Linhui Shen, Yufang Bi, Weiguo Hu

Abstract readObservational Study
In one paragraph

Observational study in JMIR aging, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yuanyue Zhu *Department of Geriatrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0009-0001-6704-7036
Kan Wang *Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0000-0002-0294-7594
Zuolin LuSchool of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.ORCID 0000-0002-9651-6065
Feika LiDepartment of Geriatrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0009-0001-3790-2126
Yu XuDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0000-0003-1045-8309
Linhui ShenDepartment of Geriatrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0000-0003-0011-5249
Yufang BiDepartment of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0000-0002-4829-5915
Weiguo HuDepartment of Geriatrics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0000-0002-3865-8014

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSarcopenia is associated with cardiovascular diseases (CVDs). However, whether changes in sarcopenia status affect CVD risk remains unclear. In addition, how indoor fuel use impacts the sarcopenia transition process is less well studied.

objectiveThis study prospectively examined the association of sarcopenia transitions with CVD risk, while exploring the effect of indoor fuel on these transitions.

methodsIn this prospective observational study, we used data from the China Health and Retirement Longitudinal Study waves 1 to 4 (2011 to 2018). In total, 8739 participants with complete data on sarcopenia and indoor fuel use were included for the indoor fuel use and sarcopenia transition analysis, and 6385 participants without previous CVDs were included for the sarcopenia transition and CVD risk analysis. Sarcopenia transition was defined according to the sarcopenia status at wave 1 (2011) and wave 2 (2013). Incident CVDs included heart diseases, stroke, and composite CVDs. Information on indoor fuel use was obtained at wave 1. Cox proportional hazards models were used to examine the effect of sarcopenia transition on incident CVDs. Logistic regression models were used to investigate the impact of indoor fuel use on these transitions.

resultsDuring a median of 7.0 years of follow-up, 1233 incident CVDs were documented. Compared to stably normal participants, progressing from a normal state to possible or confirmed sarcopenia brought increased risk of incident CVD (hazard ratio 1.42, 95% CI 1.15-1.77). Conversely, recovering to a normal state was associated with decreased risk (hazard ratio 0.72, 95% CI 0.55-0.95) for baseline participants with possible sarcopenia. In addition, clean fuel use increased the odds of achieving a possible-to-normal transformation (odds ratio 1.32, 95% CI 1.06-1.64), while both solid cooking and heating fuel use were associated with a higher risk of deterioration in sarcopenia status.

conclusionsAn unfavorable transition in sarcopenia status is associated with higher CVD risk, while reversion from possible sarcopenia to a normal state could reduce the risk. Therefore, early intervention for sarcopenia is imperative for CVD prevention, and promoting clean indoor fuel use is recommended.

Indexed as

Air Pollution, IndoorCardiovascular DiseasesSarcopeniaAgedChinaFemaleHumansIncidenceLongitudinal StudiesMaleMiddle AgedProspective StudiesRisk Factorsair pollutioncardiovascular diseasesarcopeniatransition

Identifiers

PMID40921062
PMCPMC12455154

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.